Unknown

Dataset Information

0

The role of complement activation in rhabdomyolysis-induced acute kidney injury.


ABSTRACT: Rhabdomyolysis (RM) may cause kidney damage and results primarily in acute kidney injury (AKI). Complement is implicated in the pathogenesis of renal diseases and ischemia-reperfusion injury (IRI), but the role of complement, especially its activation pathway(s) and its effect in RM-induced AKI, is not clear. This study established a rat model of AKI induced by RM via intramuscular treatment with glycerol. Cobra venom factor (CVF) was administered via tail vein injection to deplete complement 12 h prior to intramuscular injection of glycerol. We found that the complement components, including complement 3 (C3), C1q, MBL-A, factor B(fB), C5a, C5b-9, and CD59, were significantly increased in rat kidneys after intramuscular glycerol administration. However, the levels of serum BUN and Cr, renal tubular injury scores, and the number of TUNEL-positive cells decreased significantly in the CVF+AKI group. These results suggest that complement plays an important role in RM-induced AKI and that complement depletion may improve renal function and decrease renal tissue damage by reducing the inflammatory response and apoptosis.

SUBMITTER: Huang X 

PROVIDER: S-EPMC5821337 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

The role of complement activation in rhabdomyolysis-induced acute kidney injury.

Huang XuDong X   Zhao Wei W   Zhang LiXia L   Yang XinJun X   Wang LiHui L   Chen YunShuang Y   Wang JingHua J   Zhang Chao C   Wu GuangLi G  

PloS one 20180221 2


Rhabdomyolysis (RM) may cause kidney damage and results primarily in acute kidney injury (AKI). Complement is implicated in the pathogenesis of renal diseases and ischemia-reperfusion injury (IRI), but the role of complement, especially its activation pathway(s) and its effect in RM-induced AKI, is not clear. This study established a rat model of AKI induced by RM via intramuscular treatment with glycerol. Cobra venom factor (CVF) was administered via tail vein injection to deplete complement 12  ...[more]

Similar Datasets

| S-EPMC4456665 | biostudies-literature
2020-11-01 | GSE153507 | GEO
| S-EPMC6506495 | biostudies-literature
| S-EPMC5477572 | biostudies-literature
| S-EPMC8193099 | biostudies-literature
2024-09-18 | GSE264651 | GEO
| S-EPMC4713508 | biostudies-literature
| S-EPMC8318643 | biostudies-literature
2021-03-15 | E-MTAB-9145 | biostudies-arrayexpress
| S-EPMC8047323 | biostudies-literature